(Alliance News) - Shares in cash shell SalvaRx Group PLC were suspended on Tuesday as it has failed to meet AIM rules regarding a takeover.SalvaRx had until Tuesday to make an acquisition a Read More
(Alliance News) - SalvaRX Group PLC said on Friday its annual loss widened following the disposal of its SalvaRx Ltd stake, with the cash shell continuing to evaluate its options.The a loss Read More
LONDON (Alliance News) - Pires Investments PLC on Friday reported a 27% rise in the value of its unaudited net assets driven by a good performance of two of its major investments.As at the Read More
LONDON (Alliance News) - SalvaRx Group PLC on Thursday reported a widened interim loss on an impairment charge.In the six months ended June, the drug development company focused on for its Read More
LONDON (Alliance News) - SalvaRx Group PLC said Tuesday that a shareholder circular from Portage Biotech Inc has been submitted to the Canadian Securities Exchange for review.Earlier this a Read More
LONDON (Alliance News) - Shares in SalvaRx Group PLC soared on Tuesday after the company said it entered into a sale agreement for the disposal of its 94.2% stake in SalvaRx Ltd to Portage Biotech Read More
LONDON (Alliance News) - SalvaRx Group PLC said on Monday its subsidiary iOx Therapeutics Ltd has seen a significant delay in manufacturing its lead drug candidate IMM60.The cancer biotech Read More
LONDON (Alliance News) - Biotechnology firm SalvaRx Group PLC said Thursday it is making progress across all aspects of its business as it looks to gather safety and efficacy Read More
